Protheragen plays a pivotal role in supporting investigator-initiated trials (IITs) by offering expert assistance throughout the entire process. We provide guidance on preclinical research, help refine translational research ideas focused on MyD88 target-related therapies, and ensure efficient progression to clinical stages. Our services help accelerate the development of novel MyD88 target-related treatments and facilitate the exploration of new therapeutic approaches for MyD88-related diseases.